CLINICAL_TRIALS
research
· 2025-03-28
Clinical Trial Update: The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia [NA]
Summary
The clinical trial evaluating non-invasive neuromodulation to improve illness awareness in schizophrenia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Anosognosia | NA | Status: TERMINATED